ES2391563T5 - Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor - Google Patents

Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor Download PDF

Info

Publication number
ES2391563T5
ES2391563T5 ES05761637T ES05761637T ES2391563T5 ES 2391563 T5 ES2391563 T5 ES 2391563T5 ES 05761637 T ES05761637 T ES 05761637T ES 05761637 T ES05761637 T ES 05761637T ES 2391563 T5 ES2391563 T5 ES 2391563T5
Authority
ES
Spain
Prior art keywords
water
aerosol suspension
propellant gas
acid
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05761637T
Other languages
English (en)
Spanish (es)
Other versions
ES2391563T3 (es
Inventor
Christel Schmelzer
Arne Froemder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35169696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2391563(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004032322A external-priority patent/DE102004032322A1/de
Priority claimed from DE200510023334 external-priority patent/DE102005023334A1/de
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of ES2391563T3 publication Critical patent/ES2391563T3/es
Application granted granted Critical
Publication of ES2391563T5 publication Critical patent/ES2391563T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES05761637T 2004-07-02 2005-06-25 Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor Expired - Lifetime ES2391563T5 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102004032322 2004-07-02
DE102004032322A DE102004032322A1 (de) 2004-07-02 2004-07-02 Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
DE102005023334 2005-05-17
DE200510023334 DE102005023334A1 (de) 2005-05-17 2005-05-17 Aeorosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
PCT/EP2005/006865 WO2006002840A2 (de) 2004-07-02 2005-06-25 Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel

Publications (2)

Publication Number Publication Date
ES2391563T3 ES2391563T3 (es) 2012-11-27
ES2391563T5 true ES2391563T5 (es) 2022-10-26

Family

ID=35169696

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05761637T Expired - Lifetime ES2391563T5 (es) 2004-07-02 2005-06-25 Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor

Country Status (19)

Country Link
US (1) US8357352B2 (pt)
EP (1) EP1809243B2 (pt)
JP (1) JP5209963B2 (pt)
KR (1) KR101297061B1 (pt)
AR (1) AR049660A1 (pt)
AU (1) AU2005259523B2 (pt)
BR (1) BRPI0512878A (pt)
CA (1) CA2571519C (pt)
DK (1) DK1809243T4 (pt)
EA (1) EA013428B1 (pt)
EC (1) ECSP077126A (pt)
ES (1) ES2391563T5 (pt)
IL (1) IL180461A0 (pt)
MX (1) MXPA06015204A (pt)
NO (1) NO20070373L (pt)
NZ (1) NZ552869A (pt)
PL (1) PL1809243T5 (pt)
TW (1) TWI377943B (pt)
WO (1) WO2006002840A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101297061B1 (ko) 2004-07-02 2013-08-19 베링거 인겔하임 인터내셔날 게엠베하 추진제로서 ｔｇ ２２７ ｅａ 또는 ｔｇ １３４ ａ를함유하는 에어로졸 현탁액 제형
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
WO2008047239A2 (en) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
GB2442745B (en) 2006-10-13 2011-04-06 At & T Corp Method and apparatus for acoustic sensing using multiple optical pulses
GB2442746B (en) * 2006-10-13 2011-04-06 At & T Corp Method and apparatus for acoustic sensing using multiple optical pulses
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2393491B1 (en) * 2009-02-03 2020-04-22 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
BR112012012475B1 (pt) 2009-11-25 2020-03-03 Boehringer Ingelheim International Gmbh Nebulizador
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
EP2819669B1 (de) 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Neue treibgashaltige tiotropium-formulierung
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
CN116036425A (zh) 2014-05-07 2023-05-02 勃林格殷格翰国际有限公司 喷雾器、指示器装置及容器
IL247927B (en) 2014-05-07 2022-09-01 Boehringer Ingelheim Int Container, a device that turns a liquid into a fine spray and use
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
US10322198B2 (en) 2016-07-08 2019-06-18 The Procter & Gamble Company Freshening compositions comprising isopropyl myristate
WO2020028558A1 (en) 2018-07-31 2020-02-06 Microbion Corporation Bismuth-thiol compositions and methods of use

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5919435A (en) * 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
ATE177941T1 (de) * 1992-12-09 1999-04-15 Boehringer Ingelheim Pharma Stabilisierte medizinische aerosollösungen
DE69701051T2 (de) * 1993-04-30 2000-08-31 Minnesota Mining And Mfg. Co., Saint Paul Abdichtung an Aerosolbehältern
CA2166970C (en) * 1993-07-15 2000-12-19 Oh-Seung Kwon Seals for use in an aerosol delivery device
TR199701170T1 (xx) * 1995-04-14 1998-02-21 Glaxo Wellcome Inc. Beklometazon dipropionat i�in �l��lm�� doz inhaleri.
GB9513084D0 (en) * 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) * 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
JP3801348B2 (ja) 1997-07-28 2006-07-26 株式会社ヴァレオサーマルシステムズ レシーバタンク
JP4117059B2 (ja) * 1998-02-10 2008-07-09 東洋エアゾール工業株式会社 高濃度粉末エアゾール製品
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
JP4672143B2 (ja) * 1998-08-04 2011-04-20 ヤゴテック アーゲー 医薬用エーロゾル製剤
US5955958A (en) † 1998-10-05 1999-09-21 Lu; Kai Holiday candy jar with light and sound effects
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US6739333B1 (en) * 1999-05-26 2004-05-25 Boehringer Ingelheim Pharma Kg Stainless steel canister for propellant-driven metering aerosols
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
AU2001281288A1 (en) * 2000-07-18 2002-01-30 Aeropharm Technology Incorporated Modulated release therapeutic aerosols
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
DE10043509A1 (de) 2000-09-01 2002-03-14 Asta Medica Ag Feste Peptidzubereitungen für die Inhalation und deren Herstellung
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
WO2003002169A2 (en) 2001-06-26 2003-01-09 Ivax Corporation An improved aerosol actuator
KR20040081753A (ko) * 2002-02-01 2004-09-22 아스트라제네카 아베 흡입용 조성물
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
ES2342463T3 (es) * 2002-03-01 2010-07-07 Chiesi Farmaceutici S.P.A. Formulacion superfina de formoterol.
DE10214263A1 (de) † 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
DE60326082D1 (de) * 2002-11-22 2009-03-19 Lilly Co Eli Modulatoren von vitamin d rezeptoren
DK1608336T3 (da) * 2003-03-20 2008-06-02 Boehringer Ingelheim Pharma Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler
AR041873A1 (es) † 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
KR101297061B1 (ko) 2004-07-02 2013-08-19 베링거 인겔하임 인터내셔날 게엠베하 추진제로서 ｔｇ ２２７ ｅａ 또는 ｔｇ １３４ ａ를함유하는 에어로졸 현탁액 제형
DE102004032322A1 (de) 2004-07-02 2006-02-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
EP2311793A1 (en) 2004-12-17 2011-04-20 Cipla Ltd. Crystalline levosalbutamol sulphate (Form II)
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel

Also Published As

Publication number Publication date
US8357352B2 (en) 2013-01-22
DK1809243T3 (da) 2012-10-15
DK1809243T4 (da) 2022-09-05
EP1809243B2 (de) 2022-06-08
PL1809243T5 (pl) 2022-12-27
ECSP077126A (es) 2007-02-28
MXPA06015204A (es) 2007-03-15
ES2391563T3 (es) 2012-11-27
AR049660A1 (es) 2006-08-23
AU2005259523A1 (en) 2006-01-12
KR101297061B1 (ko) 2013-08-19
NZ552869A (en) 2010-06-25
WO2006002840A2 (de) 2006-01-12
TWI377943B (en) 2012-12-01
CA2571519C (en) 2013-05-14
EA200700042A1 (ru) 2007-08-31
CA2571519A1 (en) 2006-01-12
IL180461A0 (en) 2007-06-03
EP1809243A2 (de) 2007-07-25
EP1809243B8 (de) 2013-02-27
JP5209963B2 (ja) 2013-06-12
US20060002863A1 (en) 2006-01-05
NO20070373L (no) 2007-01-31
EA013428B1 (ru) 2010-04-30
BRPI0512878A (pt) 2008-04-15
KR20070042166A (ko) 2007-04-20
EP1809243B1 (de) 2012-07-18
JP2008504325A (ja) 2008-02-14
TW200612945A (en) 2006-05-01
AU2005259523B2 (en) 2011-06-09
WO2006002840A3 (de) 2006-11-16
PL1809243T3 (pl) 2013-05-31
WO2006002840A8 (de) 2012-11-08

Similar Documents

Publication Publication Date Title
ES2391563T5 (es) Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor
ES2314408T3 (es) Formulaciones de hfc en solucion que contienen un anticolinergico.
JP2786493B2 (ja) 医薬エアゾール製剤
ES2325316T3 (es) Composiciones farmaceuticas para el tratamiento del asma.
ES2211108T3 (es) Formulaciones farmaceuticas para aerosoles con dos o mas sustancias activas.
ES2774391T3 (es) Composiciones, métodos y sistemas para la administración respiratoria de dos o más agentes activos
ES2359991T3 (es) Formulaciones de solución farmacéutica estable para inhaladores de dosis medidas presurizados.
ES2199739T5 (es) Composiciones de aerosol.
US5681545A (en) Medicinal aerosol formulations
ES2182351T5 (es) Composicion farmaceutica en aerosol.
ES2249424T3 (es) Formulaciones que contienen un farmaco anticolinergico para el tratamiento de bronconeumopatias cronicas obstructivas.
ES2289832T3 (es) Composicion farmaceutica de aerosol que contiene hfa 227 y hfa 134a.
BG99760A (bg) Течна аерозолна лекарствена форма
ES2234165T3 (es) Composiciones farmaceuticas en aerosol.
ES2206619T3 (es) Formulaciones de aerosol sin tensioactivos que contienen dipropianato de beclometasona.
AU2019358585B2 (en) Pharmaceutical compositions comprising RPL554 in HFA-134a for administration by inhalation
JPH10510521A (ja) エアゾール処方物用噴射剤混合物
AU4754500A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
JPH05500664A (ja) 医療用エアロゾル製剤
SK279953B6 (sk) Aerosólové balenie so stlačeným plynom
MXPA05006383A (es) Formulaciones de soluciones de hidrofluorocarburo que contienen tiotropio.
ES2533535T3 (es) Soluciones para inhalación
AU709783B2 (en) Aerosol drug formulations containing vitamin E
US7186402B2 (en) Medicinal aerosol compositions with an amide and/or ester containing excipient compound
US20120082626A1 (en) Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders